More tools:Markets·Screener·Research·Chat

AstraZeneca PLC (AZN) Financial Statements

AstraZeneca PLC
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SB80N8
XNYS · usd
160.04▼ 2.66 (-1.63%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close162.70
Day's Range159.40 – 163.96
52-Week Range72.90 – 212.71
Volume5.1M
Avg Volume3.9M
Share Statistics
Shares Outstanding
Employees96.1K
ExchangeXNYS
Listed2009-10-23
Share count as of December 31, 2025
Loading Income Statement…
Key questions about AstraZeneca PLC (AZN)
What is AstraZeneca PLC's Market Cap?
AstraZeneca PLC's Market Cap is $248.2B, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Enterprise Value?
AstraZeneca PLC's Enterprise Value is $267.2B, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Trailing P/E?
AstraZeneca PLC's Trailing P/E is 24.3×, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Price / Sales?
AstraZeneca PLC's Price / Sales is 4.2×, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's EV / Revenue?
AstraZeneca PLC's EV / Revenue is 4.5×, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Revenue (TTM)?
AstraZeneca PLC's Revenue (TTM) is $58.7B, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Net Income (TTM)?
AstraZeneca PLC's Net Income (TTM) is $10.2B, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Diluted EPS (TTM)?
AstraZeneca PLC's Diluted EPS (TTM) is 6.60, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Net Debt?
AstraZeneca PLC's Net Debt is $19.0B, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015
Consolidated Statement of Comprehensive Income
Product Sales
Alliance Revenue
Product Revenue
Collaboration Revenue
Total Revenue
Cost of sales
Gross profit
Distribution expense
Research and development expense
Selling, general and administrative expense
Other operating income and expense
Operating profit
Finance income
Finance expense
Share of after tax losses in associates and joint ventures
Profit before tax
Taxation
Profit for the period
Other comprehensive income:
Remeasurement of the defined benefit pension liability
Net gains on equity investments measured at fair value through Other comprehensive income
Fair value movements related to own credit risk on bonds designated as fair value through profit or loss—
Tax (expense)/income on items that will not be reclassified to profit and loss
Total other comprehensive income that will not be reclassified to profit and loss, net of tax
Foreign exchange arising on consolidation
Foreign exchange arising on designated liabilities in net investment hedges
Fair value movements on cash flow hedges
Fair value movements on cash flow hedges transferred to profit and loss
Fair value movements on derivatives designated in net investment hedges
Gains/(costs) of hedging
Tax (expense)/income on items that may be reclassified subsequently to profit and loss
Total other comprehensive income that may be reclassified to profit and loss, net of tax
Other comprehensive income/(expense) for the period, net of tax
Total comprehensive income for the period
Profit attributable to:
Owners of the Parent
Non-controlling interests
Total comprehensive income attributable to:
Owners of the Parent
Non-controlling interests
Total comprehensive income for the period
Basic earnings per $0.25 Ordinary Share
Diluted earnings per $0.25 Ordinary Share